Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Good Girl Rx vs PreventiveMD

Good Girl Rx
Site position #455

Lower grade

PreventiveMD
Site position #53

Higher grade

The verdict

PreventiveMD takes it — 76.4/100 to 56.9/100.

PreventiveMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PreventiveMD offers compounded semaglutide at $119 for one month and tirzepatide at $139, with lower advertised monthly equivalents on prepaid plans and separate branded-drug memberships.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePreventiveMD +57
28
85
Dose & formulationGood Girl Rx +6
88
82
Clinical oversightPreventiveMD +27
55
82
Labs & monitoringPreventiveMD +1
52
53
FulfillmentGood Girl Rx +2
85
83
Contract termsPreventiveMD +14
41
55
Good Girl Rx · top barPreventiveMD · bottom bar

The numbers

MetricGood Girl RxPreventiveMD
WeighScore56.9/10076.4/100
GradeCC
Site position#455#53
Semaglutide$79/mo (microdose tier, 12-month plan, compounded)$83/mo (annual prepay, $999 upfront, compounded)
Tirzepatide$139/mo (microdose tier, 12-month plan, compounded)$97/mo (annual prepay, $1,168 upfront, compounded)
CoverageAll 50 states43 states; excludes DC
Brand-name accessYesYes
Oral / sublingualYesYes
Good Girl Rx

Site position #455 · C

FDAWarning letter issued to Good Girl LLC dba GoodGirlRX in February 2026. See the FDA warning-letter database.

Strengths

  • LegitScript certified
  • Multiple formats — injectable, microdose, and ODT pills — for both semaglutide and tirzepatide
  • Dispensed by licensed 503A or 503B pharmacies
  • Limited brand-name options available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • Named legal entity with a Nashville address

Where it loses points

  • The advertised rates require twelve months paid up front; billed month to month the same products are $184 and $244, roughly 2.3 times as much
  • Every plan is prepaid — the discount exists only on the 3-, 6- and 12-month terms
  • The priced products are microdoses, not labeled therapeutic doses; the standard compounded semaglutide is $134/mo and also needs a year up front
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • FDA issued Good Girl LLC dba GoodGirlRX a warning letter in February 2026; the letter is public in FDA's warning-letter database
PreventiveMD

Site position #53 · C

Strengths

  • Names Empower, Drug Crafters and Boudreaux’s New Drug Store as pharmacy choices, subject to state licensing
  • Publishes one-, three-, six- and twelve-month compound plans with the same price across doses
  • One-month compound plans are $119 for semaglutide and $139 for tirzepatide, including medication, review, supplies and shipping
  • Offers branded oral and injectable options through a separate membership model

Where it loses points

  • The $83/$97 headlines require annual prepayment of $999/$1,168; six- and twelve-month plans ship three months at a time
  • Brand-name medication costs are additional to the $49 monthly membership
  • Excludes AK, AR, MS, NJ, NM, SD, WV and DC; pharmacy-specific restrictions also apply
  • Initial review is generally asynchronous within 24–48 hours; renewal cancellation does not automatically refund a prepaid term

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard